JP2023542500A5 - - Google Patents

Info

Publication number
JP2023542500A5
JP2023542500A5 JP2023516250A JP2023516250A JP2023542500A5 JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5 JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023516250 A JP2023516250 A JP 2023516250A JP 2023542500 A5 JP2023542500 A5 JP 2023542500A5
Authority
JP
Japan
Prior art keywords
saponin
xyl
rha
fuc
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023516250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023542500A (ja
Filing date
Publication date
Priority claimed from NL2027405A external-priority patent/NL2027405B1/en
Priority claimed from PCT/NL2021/050384 external-priority patent/WO2021261992A1/en
Application filed filed Critical
Priority claimed from PCT/NL2021/050549 external-priority patent/WO2022055351A1/en
Publication of JP2023542500A publication Critical patent/JP2023542500A/ja
Publication of JP2023542500A5 publication Critical patent/JP2023542500A5/ja
Pending legal-status Critical Current

Links

JP2023516250A 2020-09-10 2021-09-09 サポニン、オリゴヌクレオチド、及びgalnacのコンジュゲート Pending JP2023542500A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
NL2026442 2020-09-10
NL2026442 2020-09-10
NL2027405A NL2027405B1 (en) 2021-01-26 2021-01-26 Semicarbazone-based saponin conjugate
NL2027405 2021-01-26
PCT/NL2021/050384 WO2021261992A1 (en) 2020-06-24 2021-06-18 Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate
NLPCT/NL2021/050384 2021-06-18
PCT/NL2021/050549 WO2022055351A1 (en) 2020-09-10 2021-09-09 Conjugate of saponin, oligonucleotide and galnac

Publications (2)

Publication Number Publication Date
JP2023542500A JP2023542500A (ja) 2023-10-10
JP2023542500A5 true JP2023542500A5 (cg-RX-API-DMAC10.html) 2024-09-02

Family

ID=99799161

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516250A Pending JP2023542500A (ja) 2020-09-10 2021-09-09 サポニン、オリゴヌクレオチド、及びgalnacのコンジュゲート

Country Status (6)

Country Link
US (1) US20240327829A1 (cg-RX-API-DMAC10.html)
EP (2) EP4210760B1 (cg-RX-API-DMAC10.html)
JP (1) JP2023542500A (cg-RX-API-DMAC10.html)
KR (1) KR20230066384A (cg-RX-API-DMAC10.html)
CN (1) CN116437965A (cg-RX-API-DMAC10.html)
IL (1) IL301214A (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117244054B (zh) * 2023-10-16 2024-06-07 国药中生生物技术研究院有限公司 具有螺甾烷-O-gal结构的化合物的佐剂用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395818T3 (es) * 2004-07-13 2013-02-15 Charite - Universitatsmedizin Berlin Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina
WO2011054811A1 (en) * 2009-11-03 2011-05-12 Santaris Pharma A/S Rna antagonists targeting hsp27 combination therapy
KR20160083876A (ko) * 2013-11-14 2016-07-12 로슈 이노베이션 센터 코펜하겐 에이/에스 ApoB 안티센스 접합체 화합물
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates

Similar Documents

Publication Publication Date Title
JP2023532040A5 (cg-RX-API-DMAC10.html)
US20240307545A1 (en) Conjugate of saponin, oligonucleotide and galnac
EP3978609A1 (en) Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
US20070060499A1 (en) Chloroquine combination drugs and methods for their synthesis
EP3992290A1 (en) Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
JP2025041739A (ja) 核酸、薬物組成物及び複合体ならびに調製方法と使用
CN110997919A (zh) 双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
KR20230043114A (ko) Galnac과 사포닌의 접합체, 상기 접합체 및 galnac-올리고뉴클레오티드 접합체를 포함하는 치료적 조성물
JP2024530839A5 (cg-RX-API-DMAC10.html)
US11485752B2 (en) Modified oligonucleotides and compound that can be used for synthesizing same
US20230277612A1 (en) Saponin derivatives for use in medicine
EP4635501A2 (en) Saponin derivatives with improved therapeutic window
JP2022542075A5 (cg-RX-API-DMAC10.html)
CA3183881A1 (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
WO2023208109A1 (zh) 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途
US20060040879A1 (en) Chloroquine coupled nucleic acids and methods for their synthesis
JP2023533693A5 (cg-RX-API-DMAC10.html)
US20250320500A1 (en) Nucleic acid, pharmaceutical composition and sirna conjugate containing the nucleic acid, preparation method therefor, and use thereof
EP4171643B1 (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
EP4210760B1 (en) Conjugate of saponin, oligonucleotide and galnac
CN104087574B (zh) 一种用于制备肝细胞靶向转递小干扰rna的方法
HK40128805A (en) Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof
HK40110483A (en) Conjugate of saponin, oligonucleotide and galnac
JP2025514180A5 (cg-RX-API-DMAC10.html)
HK40129944A (zh) Galnac和皂苷的缀合物、包含所述缀合物和galnac-寡核苷酸缀合物的治疗性组合物